Hims & Hers Health is trading 3.20% up at €27.08 on August 25, 2026, with no new company-specific catalyst clearly explaining the intraday rebound.
- Recent volatility followed reports that Visa placed the company in its monitoring program after July chargebacks linked to weight-loss subscriptions.
- Potential September fees could reach nearly $75,000.
- The broader market is modestly positive, but the move should be rechecked as trading develops.